A

Akero Therapeutics

40 employees

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2017

Funding rounds raised

Total raised

$100M

from 9 investors over 9 rounds

A

Akero Therapeutics raised $100M on June 16, 2022

Investors: Hercules Capital, Inc.

A

Akero Therapeutics raised $70M on December 12, 2018

Investors: LifeSci Venture Partners, venBio Partners, Versant Ventures and Redmile Group

A

Akero Therapeutics raised $65M on June 25, 2018

Investors: ATP (Apple Tree Partners), Versant Ventures, Atlas Venture and venBio Partners

FAQ